Granules India Limited has received the Accreditation Certificate of Foreign Drug Manufacturer from Pharmaceuticals and Medical Devices Agency (PMDA), Japan for its Jeedimetla facility, located at Jeedimetla, Quthbullapur Mandal, Medchal-Malkajgiri District, Hyderabad, Telangana. The certification has been received for accreditation categories of non-sterile Drugs, Packaging, Labelling and Storage of Drugs. Jeedimetla facility manufactures Active Pharmaceutical Ingredients (API) and Pharmaceutical Formulation Intermediates (PFIs).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
440.4 INR | +2.65% | +7.64% | +8.62% |
May. 15 | Transcript : Granules India Limited, Q4 2024 Earnings Call, May 15, 2024 | |
May. 15 | Granules India Posts Decline in Fiscal Q4 Consolidated Net Profit, Revenue | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.62% | 1.25B | |
+38.51% | 727B | |
+32.85% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.21% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- GRANULES Stock
- News Granules India Limited
- Granules India Limited Receives Accreditation Certificate of Foreign Drug Manufacturer from Pharmaceuticals and Medical Devices Agency